I. Introduction
Advances in upper limb prosthetics have typically lagged behind their lower limb counterparts. It is easy to identify two main reasons behind this “bias”: 1) the lower number of upper limb amputations implies a lower market demand for the prostheses [1],[2], making research and development of next-generation prostheses harder to justify; 2) the significantly larger number of actuated degrees of freedom (DOFs) involved in controlling the upper extremities requires many more biosignals (even compared to 0, such as in passive prostheses [3]) for a biomimetic control of the prostheses.